Merck completes acquisition of Austrian vaccine developer Themis Bioscience
Pharma giant Merck has wrapped up its previously announced acquisition of Austrian vaccine developer Themis Bioscience. The Austrian…
Mylan gets favorable court decision in Biogen’s Tecfidera patent case
Dutch generic drugmaker Mylan said that the US District Court for the Northern District of West Virginia has…
Mylan gets favorable court decision in Biogen’s Tecfidera patent case
Dutch generic drugmaker Mylan said that the US District Court for the Northern District of West Virginia has invalidated Biogen’s Tecfidera patent U.S. Patent No. 8,399,514 for lack of written description. According to the company, the 8,399,514 patent claimed methods for the treatment of multiple sclerosis (MS) with a dose of 480 mg/day of dimethyl […]
Ultragenyx Pharmaceutical, Kyowa Kirin bag Crysvita FDA approval for TIO
Crysvita FDA approval for TIO : Ultragenyx Pharmaceutical and Kyowa Kirin have secured approval for their recombinant fully…
Polycythemia vera treatment : Protagonist Therapeutics’ PTG-300 gets FDA ODD
Protagonist Therapeutics has bagged the orphan drug designation (ODD) from the US Food and Drug Administration (FDA) for…
Polycythemia vera treatment : Protagonist Therapeutics’ PTG-300 gets FDA ODD
Protagonist Therapeutics has bagged the orphan drug designation (ODD) from the US Food and Drug Administration (FDA) for PTG-300 for polycythemia vera treatment. Polycythemia vera is a type of blood cancer, which is mainly characterized by the increased production of red blood cells. According to the California-based biopharma company, PTG-300 is an injectable synthetic peptide […]
Gene therapy company 4D Molecular Therapeutics raises $70m in Series C round
California-based gene therapy company 4D Molecular Therapeutics (4DMT), which is focused on adeno-associated virus (AAV) gene therapy vector…
Dexamethasone improves survival of COVID-19 patients in RECOVERY trial
The University of Oxford said that steroid dexamethasone has succeeded in reducing death in the ongoing RECOVERY trial…
Catalent wins contract to manufacture AZD1222 COVID-19 vaccine candidate
US-based Catalent said that its subsidiary Catalent Biologics has bagged a contract to provide vial filling and packaging…
Lilly Covid drug trial : US pharma giant launches phase 3 trial of baricitinib
Lilly Covid drug trial : Eli Lilly and Company has enrolled the first patient in a phase 3…